MIDLOTHIAN, Va., May 7, 2020 /PRNewswire/ -- This week, the first patients are enrolling in two phase 2 clinical trials for COVID-19 using Pulmotect's PUL-042, an inhaled immunomodulatory agent to ...
Various lung conditions make it harder for people to breathe, resulting in shortness of breath, wheezing, and chronic coughing. There are a variety of treatments available to help patients breathe ...
The Food and Drug Administration (FDA) has approved PARI’s eRapid Nebulizer System (eRapid), the first electronic nebulizer to deliver Pulmozyme (dornase alfa [recombinant human DNase]; Genentech) for ...
An albuterol nebulizer relieves muscle tightening in the airways to help a person breathe. The nebulizer turns liquid medication into a mist, helping it reach the lungs faster. Generally, nebulizers ...
Respiratory devicemaker PARI picked up an approval from the FDA for its eRapid nebulizer system, which is the first electronic one to deliver Genentech's cystic fibrosis treatment Pulmozyme. A ...
A nebulizer transforms medicine into a breathable mist. The person inhales the mist, allowing the body to absorb the medicine quickly and effectively. In this article, we look at the benefits and uses ...
LANGHORNE, Pa., December 02, 2025--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the European ...
Sellbyville, DE -- (SBWIRE) -- 06/18/2019-- Pneumatic Nebulizers Market size is set to exceed USD 875 million by 2024; according to a new research report by Global Market Insights. Rising elderly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback